Attached files
file | filename |
---|---|
EX-3.3 - EX-3.3 - Axsome Therapeutics, Inc. | a2226220zex-3_3.htm |
EX-10.1 - EX-10.1 - Axsome Therapeutics, Inc. | a2226220zex-10_1.htm |
EX-10.4 - EX-10.4 - Axsome Therapeutics, Inc. | a2226220zex-10_4.htm |
S-1 - S-1 - Axsome Therapeutics, Inc. | a2226220zs-1.htm |
EX-4.3 - EX-4.3 - Axsome Therapeutics, Inc. | a2226220zex-4_3.htm |
EX-3.1 - EX-3.1 - Axsome Therapeutics, Inc. | a2226220zex-3_1.htm |
EX-4.2 - EX-4.2 - Axsome Therapeutics, Inc. | a2226220zex-4_2.htm |
EX-23.2 - EX-23.2 - Axsome Therapeutics, Inc. | a2226220zex-23_2.htm |
EX-10.2 - EX-10.2 - Axsome Therapeutics, Inc. | a2226220zex-10_2.htm |
EX-10.5 - EX-10.5 - Axsome Therapeutics, Inc. | a2226220zex-10_5.htm |
EX-10.3 - EX-10.3 - Axsome Therapeutics, Inc. | a2226220zex-10_3.htm |
Exhibit 21.1
Subsidiaries of Axsome Therapeutics, Inc.
Legal Name |
|
Jurisdiction of Organization or Incorporation |
Axsome Therapeutics Limited |
|
United Kingdom |
|
|
|
Axsome Therapeutics Australia Pty Ltd |
|
Australia |